MIM
BNR

Monashee Investment Management’s Burning Rock Biotech BNR Stock Holding History

Monashee Investment Management’s Portfolio BNR Stock Details BNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-8,000
Closed -$1.85M – 385
2020
Q4 		$1.85M Buy
+8,000
New +$2.15M 0.24% 115
2020
Q3 		– Sell
-3,000
Closed -$810K – 186
2020
Q2 		$810K Buy
+3,000
New +$822K 0.12% 138

Other funds holding BNR

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Monashee Investment Management's BNR Position: Q1 2021 in Review

Monashee Investment Management sold out of Burning Rock Biotech (BNR) in Q1 2021, closing a stake of 8,000 shares — an estimated $1.85M sold.

Monashee Investment Management first reported a position in BNR in Q2 2020 and held it in 2 quarters. The position peaked at $1.85M in Q4 2020. 54 funds tracked by Wall St. Rank hold BNR as of Q1 2021.

  • Monashee Investment Management reported no remaining Burning Rock Biotech position as of Q1 2021 after selling out during the quarter.
  • Monashee Investment Management sold 8,000 Burning Rock Biotech shares in Q1 2021, an estimated $1.85M.
  • Monashee Investment Management first reported a position in Burning Rock Biotech in Q2 2020 and held it in 2 quarters.
  • Monashee Investment Management's Burning Rock Biotech position peaked at $1.85M in Q4 2020.
  • 54 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q1 2021.

Based on Monashee Investment Management's 13F filing for Q1 2021, filed 14 May 2021.